South Australia
Controlled Substances (General) Regulations 2000
under the Controlled Substances Act 1984

Contents
1	Short title
4	Interpretation
4A	Electronic drug detection
5	Declaration of controlled drugs, controlled precursors and controlled plants
6	Prescribed quantities of controlled drugs, controlled precursors and controlled plants
6A	Prescribed professions (section 31(1))
7	Prescribed number of cannabis plants (section 33K)
8	Exemption from prohibition of possession of injecting equipment
8AA	Prescribed equipment (section 33LA)
8AB	Prescribed quantity of mixture containing controlled precursors (section 33LB)
8AC	Prescribed equipment (sections 33LB and 33J)
8A	No accessorial liability in prescribed circumstances
9	Prescribed place
9A	Expiation fees for simple cannabis offences
9B	Simple cannabis offences
10	Taking of cannabis samples (section 52E(6))
11	Prescribed manner of initiation of analysis and prescribed fee
12	Prescribed form of certificate of analysis (section 53(4))
13	Research permits (section 56(1))
14	Prescribed professional associations
15	Corresponding laws
16	Copies of codes etc to be kept available for public inspection
Schedule 1—Controlled drugs
Part 1—Controlled drugs other than drugs of dependence
Part 2—Drugs of dependence
Schedule 2—Controlled precursors
Schedule 3—Controlled plants
Part 1—Controlled plants other than cannabis plants
Part 2—Cannabis plants
Schedule 4—Certificate of analysis
Schedule 5—Expiation fees
Legislative history

1—Short title
These regulations may be cited as the Controlled Substances (General) Regulations 2000.
4—Interpretation
In these regulations, unless the contrary intention appears—
Act means the Controlled Substances Act 1984;
DDU means discrete dosage unit;
hemp seed oil means the oil obtained by cold expression from the seeds of cannabis;
midwife means a person registered as a midwife under the law of this State.
4A—Electronic drug detection
	(1)	For the purposes of paragraph (b) of the definition of general drug detection in section 4(1) of the Act, an electronic drug detection system may only be used in a manner consistent with this regulation.
	(2)	An electronic drug detection system may only be used in relation to a person in accordance with the following:
	(a)	by taking samples of particulate matter from—
	(i)	the outside of the person's clothing; and
	(ii)	the person's hands,
for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant;
	(b)	the person cannot be required to remove, undo or rearrange any clothing for the purpose of taking such samples from the person's clothing; 
	(c)	in taking such samples from the person's clothing, care must be taken to avoid disturbing the person's clothing.
	(3)	An electronic drug detection system may only be used in relation to property (other than a vehicle) by taking samples of particulate matter from the outside of the property for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant.
	(4)	An electronic drug detection system may only be used in relation to a vehicle in accordance with the following:
	(a)	by taking samples of particulate matter from both the exterior and interior of the vehicle (but not from the inside of any internal storage compartment) for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant;
	(b)	articles must not be removed from the vehicle for the purpose of taking such samples.
	(5)	For the purposes of this regulation, samples of particulate matter may be taken by swabbing, wiping or otherwise touching a surface to obtain a sample of particles from that surface.
	(6)	In this regulation—
internal storage compartment, in relation to a vehicle, means a glove box, drawer, cupboard, pocket or other similar compartment within the vehicle that is designed by the manufacturer—
	(a)	for the storage of items in the vehicle; and
	(b)	to be capable of being sealed or closed,
but does not include general internal space within a vehicle such as the rear of a station wagon, panel van or van, the boot of a car or any other similar space;
vehicle includes a caravan, trailer or anything else being towed by the vehicle.
5—Declaration of controlled drugs, controlled precursors and controlled plants
	(1)	In accordance with section 12(4) of the Act, the following substances are declared to be controlled drugs:
	(a)	the natural or synthetic form of a substance listed in Schedule 1;
	(b)	any salt, derivative or isomer of the natural or synthetic form of a substance listed in Schedule 1 and any salt of such derivative or isomer;
	(c)	any analogue of the natural or synthetic form of a substance listed in Schedule 1 (being an analogue having a substantially similar chemical structure to the substance, but differing in elemental composition due to the addition, deletion or replacement of any substituent element or group);
	(d)	any homologue of the natural or synthetic form of a substance listed in Schedule 1 (being a homologue differing from the substance by 1 or more carbon containing groups (including methylene groups) in the chemical structure);
	(e)	any of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.
	(2)	In accordance with section 12(4a) of the Act, the following substances are declared to be controlled precursors:
	(a)	the natural or synthetic form of a substance listed in Schedule 2;
	(b)	any salt, isomer, ester, ether, ketal, acetal, acetate, hydroxide, oxime, amide, imine, acid chloride, nitrile, anhydride, halogen substituent, epoxide, diol or any analogue or derivative of the natural or synthetic form of a substance listed in Schedule 2;
	(c)	any of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.
	(3)	In accordance with section 12(4b) of the Act, the following plants are declared to be controlled plants:
	(a)	a growing plant listed in Schedule 3 Part 1;
	(b)	a cutting taken from a plant listed in Schedule 3 Part 1 (provided that the cutting has been planted or otherwise placed in a growing medium).
6—Prescribed quantities of controlled drugs, controlled precursors and controlled plants
	(1)	For the purposes of the definition of large commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug or controlled plant prescribed as a large commercial quantity of the drug or plant in its pure form is—
	(a)	in the case of a controlled drug—the amount (if any) listed in the column headed "Large commercial (pure)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
	(c)	in the case of a controlled plant—the amount (if any) listed in the column headed "Large commercial" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
	(2)	For the purposes of the definition of large commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug or controlled precursor prescribed as a large commercial quantity for any mixture containing the drug or precursor is—
	(a)	in the case of a controlled drug—the amount (if any) listed in the column headed "Large commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
	(b)	in the case of a controlled precursor—the amount (if any) listed in the column headed "Large commercial (mixed)" of the table in Schedule 2 opposite the entry listing the controlled precursor.
	(2a)	For the purposes of the definition of large commercial quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as a large commercial quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the column headed "Large commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
	(3)	For the purposes of the definition of commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug or controlled plant prescribed as a commercial quantity of the drug or plant in its pure form is—
	(a)	in the case of a controlled drug—the amount (if any) listed in the column headed "Commercial (pure)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
	(c)	in the case of a controlled plant—the amount (if any) listed in the column headed "Commercial" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
	(4)	For the purposes of the definition of commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug or controlled precursor prescribed as a commercial quantity for any mixture containing the drug or precursor is—
	(a)	in the case of a controlled drug—the amount (if any) listed in the column headed "Commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
	(b)	in the case of a controlled precursor—the amount (if any) listed in the column headed "Commercial (mixed)" of the table in Schedule 2 opposite the entry listing the controlled precursor.
	(4a)	For the purposes of the definition of commercial quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as a commercial quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the column headed "Commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
	(5)	For the purposes of the definition of trafficable quantity in section 4(1) of the Act, the quantity of a particular controlled plant prescribed as a trafficable quantity of the controlled plant in its pure form is the amount (if any) listed in the column headed "Trafficable" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
	(6)	For the purposes of the definition of trafficable quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug prescribed as a trafficable quantity for any mixture containing the controlled drug is the amount (if any) listed in the column headed "Trafficable (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
	(7)	For the purposes of the definition of trafficable quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as a trafficable quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the column headed "Trafficable (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
6A—Prescribed professions (section 31(1))
	(1)	For the purposes of section 31(1)(a)(i) of the Act, the profession of midwifery is prescribed.
	(2)	However, subregulation (1) only applies in respect of members of the profession of midwifery who are midwives.
7—Prescribed number of cannabis plants (section 33K)
For the purposes of section 33K of the Act, the prescribed number of cannabis plants is 5.
8—Exemption from prohibition of possession of injecting equipment
Section 33L(1)(c) of the Act does not apply to a person having in his or her possession a syringe or needle for use in connection with the administration of a controlled drug.
8AA—Prescribed equipment (section 33LA)
	(1)	For the purposes of section 33LA of the Act—
	(a)	the following equipment (being equipment that is, or may at some stage have been, capable of being used for hydroponic cannabis cultivation) is prescribed:
	(i)	metal halide lights, high pressure sodium lights and mercury vapour lights of 400 watts or greater;
	(ii)	ballast boxes;
	(iii)	devices (including control gear, lamp mounts and reflectors) designed to amplify light or heat;
	(iv)	carbon filters designed to filter air within a room, or from 1 area of a building to another or to outside;
	(v)	cannabis bud or head strippers;
	(vi)	units designed to contain plants and rotate around a light source so that the plants grow hydroponically while being exposed to a consistent degree of light or heat or both; and
	(b)	the following equipment (being equipment that is, or may at some stage have been, capable of being used in the manufacture of controlled drugs) is prescribed:
	(i)	condensers;
	(ii)	distillation heads;
	(iii)	heating mantles;
	(iv)	rotary evaporators;
	(v)	heater‑stirrers;
	(vi)	mechanical‑stirrers;
	(vii)	pressure reaction vessels;
	(viii)	separatory funnels;
	(ix)	buchner flasks;
	(x)	in‑line membrane filters;
	(xi)	reaction vessels;
	(xii)	splash heads;
	(xiii)	tube furnaces;
	(xiv)	manual or mechanical tablet presses, including parts for such an item;
	(xv)	manual or mechanical encapsulators, including parts for such an item;
	(xvi)	an item modified to perform the function of a condenser, distillation head, splash head, pressure reaction vessel or tube furnace; and
	(c)	a device comprising a hydraulic compression system and a die that is, or may at some stage have been, capable of being used to compress a powdered substance into blocks is prescribed.
	(2)	Equipment described in subregulation (1) is prescribed for the purposes of section 33LA of the Act regardless of whether the equipment is in working order or has been, or is being, modified in any way.
8AB—Prescribed quantity of mixture containing controlled precursors (section 33LB)
The quantity of a mixture containing a particular controlled precursor prescribed for the purposes of section 33LB for any mixture containing the controlled precursor is the amount (if any) listed in the column headed "Commercial (mixed)" of the table in Schedule 2 opposite the entry listing the controlled precursor.
8AC—Prescribed equipment (sections 33LB and 33J)
	(1)	For the purposes of sections 33LB(2)(b) and 33J(2)(b) of the Act—
	(a)	the following equipment (being equipment that is, or may at some stage have been, capable of being used in the manufacture of controlled drugs) is prescribed:
	(i)	condensers;
	(ii)	distillation heads;
	(iii)	heating mantles;
	(iv)	rotary evaporators;
	(v)	heater‑stirrers;
	(vi)	mechanical‑stirrers;
	(vii)	pressure reaction vessels;
	(viii)	separatory funnels;
	(ix)	buchner flasks;
	(x)	in‑line membrane filters;
	(xi)	reaction vessels;
	(xii)	splash heads;
	(xiii)	tube furnaces;
	(xiv)	manual or mechanical tablet presses, including parts for such an item;
	(xv)	manual or mechanical encapsulators, including parts for such an item;
	(xvi)	an item modified to perform the function of a condenser, distillation head, splash head, pressure reaction vessel or tube furnace; and
	(b)	a device comprising a hydraulic compression system and a die that is, or may at some stage have been, capable of being used to compress a powdered substance into blocks is prescribed.
	(2)	Equipment described in subregulation (1) is prescribed for the purposes of sections 33LB and 33J of the Act regardless of whether the equipment is in working order or has been, or is being, modified in any way.
8A—No accessorial liability in prescribed circumstances
	(1)	For the purposes of section 33S, a circumstance consisting of the sale or supply of syringes or needles, or the giving of advice or instruction on the safe use of syringes or needles, by—
	(a)	a medical practitioner; or
	(b)	a pharmacist; or
	(c)	a person acting in the course of a health risk minimisation program,
is prescribed.
	(2)	In this regulation—
health risk minimisation program means a program—
	(a)	designed to facilitate—
	(i)	the supply to intravenous drug users of sterile syringes and sterile needles, and any associated equipment, to prevent the spread of infectious diseases and minimise health risks associated with intravenous drug use; and
	(ii)	the giving out of information concerning safe practices in the use of syringes and needles to prevent the spread of infectious diseases; and
	(b)	declared by the Minister, by notice in writing given personally or by post to the person responsible for conducting the program, to be a health risk minimisation program for the purposes of this regulation.
	(3)	The Minister may, by subsequent notice in writing given personally or by post to the person responsible for conducting the program, vary or revoke the declaration.
9—Prescribed place
For the purposes of section 44(1)(da) of the Act, a prescribed place is any place where members of the public are gathered for an entertainment or an event or activity of any kind, whether admission is open, procured by the payment of money or restricted to members of a club or a class of persons with some other qualification or characteristic.
9A—Expiation fees for simple cannabis offences
In accordance with section 45A(3) of the Act, the fees fixed for the expiation of simple cannabis offences are set out in Schedule 5.
9B—Simple cannabis offences
	(1)	For the purposes of paragraph (a) of the definition of simple cannabis offence in section 45A(8) of the Act, the prescribed number of cannabis plants is 1.
	(2)	For the purposes of paragraph (b) of the definition of simple cannabis offence in section 45A(8) of the Act, the following quantities of cannabis, cannabis resin and cannabis oil are prescribed:
	(a)	in the case of cannabis—100 grams;
	(b)	in the case of cannabis resin—20 grams;
	(c)	in the case of cannabis oil—0 millilitres.
	(3)	For the purposes of paragraph (c) of the definition of simple cannabis offence in section 45A(8) of the Act, a motor vehicle, train, tram or any other vehicle is, while in a public place, prescribed.
10—Taking of cannabis samples (section 52E(6))
	(1)	For the purposes of section 52E(6) of the Act, where samples of cannabis are to be taken, they must be taken as follows:
	(a)	in the case of a crop of growing or newly harvested plants consisting of—
	(i)	10 or fewer plants—at least one sample must be taken;
	(ii)	11 to 20 plants—at least 5 samples must be taken;
	(iii)	21 to 100 plants—at least 10 samples must be taken;
	(iv)	more than 100 plants—at least 20 samples must be taken;
	(b)	in the case of dried and packaged cannabis, a sample of at least 10 grams must be taken from each package.
	(2)	Each sample must be separately packaged and identified.
	(3)	For the purposes of this regulation—
samples, in relation to plants, means—
	(a)	if the plants are immature (that is to say, they do not have any fully developed leaves) the plants themselves;
	(b)	if the plants are mature, a fully developed leaf or flowerhead (taken from separate plants if more than one sample is required).
11—Prescribed manner of initiation of analysis and prescribed fee
For the purposes of section 53(3) of the Act—
	(a)	the prescribed manner of initiating an analysis is by notice in writing, addressed to the analyst, describing the substance to be analysed and signed by the person initiating the analysis; and
	(b)	the prescribed fee for analysis is $207 per substance.
12—Prescribed form of certificate of analysis (section 53(4))
For the purposes of section 53(4) of the Act, the form set out in Schedule 4 is the prescribed form for the certificate of analysis.
13—Research permits (section 56(1))
An application for a research permit under section 56(1) of the Act must be made in writing to the Minister and signed by the applicant.
14—Prescribed professional associations
For the purposes of section 58(1a) of the Act, the following professional associations are prescribed:
	(a)	in the case of publishing information to medical practitioners—
	(i)	Adelaide Northern Division of General Practice; and
	(ii)	Australian Medical Association; and
	(iii)	Murray Mallee Division of General Practice; and
	(iv)	Western Division of Mental Health; and
	(v)	Royal Australian College of General Practitioners;
	(b)	in the case of publishing information to pharmacists—
	(i)	Pharmaceutical Society of Australia (SA Branch); and
	(ii)	Pharmacy Guild of Australia (SA Branch); and
	(iii)	Friendly Society Medical Association.
15—Corresponding laws
For the purposes of section 61(4) of the Act, the following laws are prescribed:
	(a)	the Drugs of Dependence Act 1989 of the Australian Capital Territory;
	(b)	the Drugs Misuse and Trafficking Act 1985 of New South Wales;
	(c)	the Misuse of Drugs Act of the Northern Territory;
	(d)	the Drugs Misuse Act 1986 of Queensland;
	(e)	the Poisons Act 1971 of Tasmania;
	(f)	the Drugs, Poisons and Controlled Substances Act 1981 of Victoria;
	(g)	the Misuse of Drugs Act 1981 of Western Australia.
16—Copies of codes etc to be kept available for public inspection
For the purposes of section 63(5a) of the Act, the office of Drug and Alcohol Services South Australia at 168 Greenhill Road, Parkside is specified as the place at which copies of any relevant codes, standards, pharmacopoeia and other documents must be kept and made available for inspection by members of the public.

Schedule 1—Controlled drugs
Part 1—Controlled drugs other than drugs of dependence

	Large commercial (pure)	Large commercial (mixed)	Commercial (pure)	Commercial (mixed)	Trafficable (mixed)	
	kg	kg/DDUs	kg	kg/DDUs	g/DDUs	
Acetorphine		2		0.5	3	
Acetyl‑alpha‑methylfentanyl		0.005		0.00125	0.0075	
Allylprodine		1		0.25	1.5	
Alpha‑methylfentanyl		0.005		0.00125	0.0075	
Alpha‑methylthiofentanyl		0.005		0.00125	0.0075	
Alpha‑methyltryptamine (α‑MT)		1kg or 100 DDUs		0.2kg or 20 DDUs	2g or 10 DDUs	
5-(2‑aminopropyl)indan		1		0.25	3	
3-(2‑aminopropyl)indole (AMT)		0.2		0.05	5	
Benzethidine		10		2.5	15	
Benzoylecgonine		1		0.25	3	
Benzylpiperazines (not otherwise listed in this Schedule)		1		0.25	3	
1‑Benzylpiperazine (BZP)		1		0.25	3	
Beta‑hydroxyfentanyl		0.005		0.00125	0.0075	
Beta‑hydroxy‑3‑methylfentanyl		0.005		0.00125	0.0075	
4‑Bromo‑2,5-dimethoxyamphetamine		0.2		0.05	5	
1‑(8‑Bromobenzo[1,2‑b:4,5‑b]
difuran‑4‑yl)‑2‑aminopropane (Bromo‑Dragonfly)		100 DDUs		20 DDUs	10 DDUs	
Bufotenine		2		0.5	2	
1,4‑Butanediol		2		0.5	50	
Cannabis - oil (other than hemp seed oil)	2	10	1	2	25	
Cannabis - resin	2	10	1	2	25	
Cannabis - plant material including flowering and fruiting tops, leaves, seeds or stalks but not including oil or resin	2	12.5	1	2.5	250	
Cathinones (not otherwise listed in this Schedule)		5		1.25	6	
4‑Chloro‑2,5‑
dimethoxyamphetamine		0.2kg or 100 DDUs		0.05kg or 20 DDUs	5g or 10 DDUs	
1‑(3‑Chlorophenyl)piperazine		1		0.25	3	
Clonitazene		5		1.25	7.5	
Codoxime		10		2.5	15	
4‑Cyano‑2‑dimethylamino‑4,4‑
diphenylbutane (methadone intermediate)		2		0.5	3	
Delta‑9‑tetrahydrocannabinol	4	25	1	10	25	
Desomorphine		2		0.5	3	
N,N‑Di‑(N)‑propyltryptamine (DPT)		1kg or 100 DDUs		0.2kg or 20 DDUs	2g or 10 DDUs	
Diampromide		5		1.25	7.5	
Diethylthiambutene		5		1.25	7.5	
N,N‑Diethyltryptamine		2kg or 100 DDUs		0.5kg or 20 DDUs	3g or 10 DDUs	
Dihydrohydroxymorphine		10		2.5	250	
Dimenoxadol		10		2.5	125	
Dimepheptanol		10		2.5	125	
N,N‑Dimethyl‑5‑methoxy
tryptamine (5‑MeO‑DMT)		1kg or 100 DDUs		0.2kg or 20 DDUs	2g or 10 DDUs	
N,N-Dimethylamphetamine						
3-(1,2-Dimethylheptyl)‑1‑hydroxy-7,8,9,10-tetrahydro‑6, 6,9‑trimethyl‑6h‑dibenzo (b,d) pyran (DMHP)		2		0.5	3	
Dimethylthiambutene		5		1.25	7.5	
N,N‑Dimethyltryptamine		2kg or 100 DDUs		0.5kg or 20 DDUs	3g or 10 DDUs	
2,5‑Dimethoxy‑4‑
bromophenethylamine		1		0.5	2	
2,5‑Dimethoxy‑4‑
chlorophenethylamine		1		0.5	2	
2,5-Dimethoxy‑4-ethylthiophenethylamine		1		0.5	2	
2,5-Dimethoxy‑4-iodophenethylamine		1		0.5	2	
2,5‑Dimethoxy‑4‑
methylphenethylamine		1		0.5	2	
2,5-Dimethoxy‑4‑(N)‑
propylthiophenethylamine		1kg or 100 DDUs		0.5kg or 20 DDUs	2g or 10 DDUs	
Dioxaphetylbutyrate		2		0.5	3	
Ecgonine		1		0.25	3	
4,5‑Ethylenedioxy‑3-methoxyamphetamine						
Ethylmethylthiambutene		5		1.25	7.5	
N‑Ethyl-1-phenylcyclohexylamine		0.4		0.1	0.0075	
Eticyclidine (PCE)		0.004		0.001	0.0075	
Etonitazene		5		1.25	7.5	
Etorphine		5		1.25	7.5	
Etoxeridine		5		1.25	7.5	
Fenethylline		2		0.5	3	
4‑Fluoro‑N‑methylamphetamine		1		0.5	2	
Furethidine		1		0.25	1.5	
Harmaline		5		1.25	20	
Harmine		5		1.25	20	
Harmines (not otherwise listed in this Schedule)		5		1.25	20	
Heroin (diacetylmorphine/diamorphine)	0.75	1	0.1	0.2	2	
3‑Hexyl‑1‑hydroxy‑7,8,9,10-tetrahydro-6,6,9- trimethyl‑6H‑dibenzo (b,d)pyran	4	25	1	10	25	
Hydroxyamphetamine		5		1.25	6	
4‑Hydroxybutanoic acid (GHB)		2		0.5	50	
Hydroxyfentanyl		0.005		0.00125	0.0075	
Hydroxy‑3‑methylfentanyl		0.005		0.00125	0.0075	
Hydroxypethidine		1		0.25	3	
4‑Iodo‑2,5‑dimethoxy
amphetamine		0.2kg or 100 DDUs		0.05kg or 20 DDUs	5g or 10 DDUs	
Isomethadone		2		0.5	3	
Ketobemidone		2		0.5	3	
Levomethorphan (excluding its stereoisomers)		2		0.5	3	
Lysergamide		0.015		0.005	0.015	
Lysergic acid		0.015		0.005	0.015	
Lysergic acid diethylamide (LSD)		0.015kg or 100 DDUs		0.005kg or 20 DDUs	0.015g or 10 DDUs	
Mecloqualone		5		1.25	15	
Meprodine		1		0.25	1.5	
Mescaline (3,4,5-Trimethoxyphenethylamine)		0.2		0.05	2	
Metazocine		7		1.75	125	
Methadol		5		1.25	15	
Methaqualone		5		1.25	7.5	
Methcathinones (not otherwise listed in this Schedule)		5		1.25	6	
1‑(4‑Methoxyphenyl)piperazine		1		0.25	3	
5‑Methoxy‑α‑methyltryptamine		0.2kg or 100 DDUs		0.05kg or 20 DDUs	5g or 10 DDUs	
4‑Methyl‑2,5‑dimethoxy
amphetamine		1kg or 100 DDUs		0.5kg or 20 DDUs	2g or 10 DDUs	
N‑Methyl‑1‑(1,3‑benzodioxol‑ 
5‑yl)‑2‑butanamine(MBDB)		0.75		0.1	2	
4‑methylaminorex	1	2.5	0.25	1.25	6	
Methyldesorphine		2		0.5	3	
3,4‑Methylenedioxyamphetamine (MDA)	0.75	1	0.1	0.5	2	
3,4‑Methylenedioxymethyl
amphetamine (MDMA)	0.75	1	0.1	0.5	2	
3,4‑Methylenedioxy‑N‑ethyl
amphetamine (MDEA)	0.75	1	0.1	0.5	2	
3‑Methylfentanyl		0.005		0.00125	0.0075	
4‑Methylmethcathinone (Mephedrone)		5		1.25	6	
2‑Methyl‑3‑morpholino‑1,1-diphenylpropane carboxylic acid (Moramide intermediate)		2		0.5	3	
1‑Methyl‑4‑phenyl-4-propionoxypiperidine		1		0.25	3	
3‑Methylthiofentanyl		0.005		0.00125	0.0075	
Metopon		2		0.5	3	
Mitragynine						
Monoacetylmorphine		1.5		0.6	30	
Morpheridine		1.5		0.6	30	
Morphinone		1.5		0.6	30	
Muscimol		2		0.5	125	
Myrophine		20		5	30	
Nicocodine		4		1	500	
Nicodicodine		4		1	500	
Nicomorphine		4		1	500	
Noracylmethadol		2		0.5	3	
Noracymethadol		5		1.25	15	
Norlevorphanol		1		0.25	1.5	
Normorphine		20		5	30	
Norpipanone		10		2.5	15	
Opium (except where it is a drug of dependence)		4		1	30	
Parafluorofentanyl		0.005		0.00125	0.0075	
Parahexyl		0.2		0.05	5	
Paramethoxyamphetamine (4‑Methoxyamphetamine or PMA)	0.75	1	0.1	0.5	2	
Paramethoxymethamphetamine (PMMA)	0.75	1	0.1	0.5	2	
Phenacylmorphan		4		1	250	
Phenadoxone		10		2.5	15	
Phenampromide		10		2.5	15	
Phenazocine		1		0.25	1.5	
Phencyclidine		0.004		0.001	0.0075	
N-Phenethyl-4-piperidone (NPP)						
Phenethylamines (not otherwise listed in this Schedule)	0.75	1	0.1	0.5	2	
Phenomorphan		5		1.25	7.5	
1‑(1-Phenylcyclohexyl)
pyrrolidine		0.004		0.001	0.0075	
1‑Phenylethyl‑4-acetoxypiperidine		0.004		0.001	0.0075	
1‑(2‑Phenylethyl)‑4‑phenyl‑4-acetyloxypiperidine (PEPAP)						
Piminodine		10		2.5	15	
Piperazines (not otherwise listed in this Schedule)		1		0.5	2	
Prodine		1		0.25	1.5	
Proheptazine		1		0.25	1.5	
Properidine		28		7	40	
Propoxyphene		2		0.5	250	
Psilocin (3-(2‑Dimethylaminoethyl)‑4-hydroxyindole)		1		0.25	100	
Psilocybin		1		0.25	100	
Rolicyclidine (PHP or PCPY)		0.004		0.001	0.0075	
Salvinorin A		0.2		0.05	5	
Tenocyclodine (TCP)		0.004		0.001	0.0075	
Tetrahydrocannabinol (other than tetrahydrocannabinols—	2	12.5	1	2.5	250	
	(a)	included in Part 2 of this Schedule;						
	(b)	at a level not exceeding 50 mg/kg contained in hemp seed oil labelled "not for human internal use or consumption";						
	(c)	at a level not exceeding 50 mg/kg contained in a product containing hemp seed oil designed for human external use only)						
Thiambuten		5		1.25	7.5	
1‑(1‑(2-Thienyl)
cyclohexyl)piperidine		0.004		0.001	0.0075	
Thiofentanyl		0.005		0.00125	0.0075	
1‑(3-Trifluoromethylphenyl) 
piperazine (TFMPP)		1		0.2	2	
Trimeperidine		10		2.5	15	
Tryptamines (not otherwise listed in this Schedule)		1kg or 100 DDUs		0.2kg or 20 DDUs	2g or 10 DDUs	
Part 2—Drugs of dependence
Note—
A reference in the table below to schedule 2, 3 or 4 is a reference to the corresponding schedule of the Uniform Poisons Standard as incorporated into the Controlled Substances (Poisons) Regulations 1996.

	Large commercial (pure)	Large commercial (mixed)	Commercial (pure)	Commercial (mixed)	Trafficable (mixed)	
	kg	kg	kg	kg	g	
Acetyldihydrocodeine		10		2.5	15	
Acetylmethadol		5		1.25	15	
Acetylmorphines (except monoacetylmorphine and heroin (diacetylmorphine/diamorphine))						
Alfentanil		2		0.5	3	
Alphacetylmethadol						
Alphaprodine						
Amphetamine	0.75	1	0.1	0.5	2	
Amphetamines (not otherwise listed in this Schedule)		1		0.5	2	
Amylobarbitone (except when included in schedule 4)		4		1	125	
Anileridine		10		2.5	15	
Benzylmorphine (3‑benzylmorphine)		5		1.25	7.5	
Bezitramide		5		1.25	7.5	
Buprenorphine		0.04		0.01	0.06	
Butobarbitone		4		1	125	
Butorphanol		2		0.5	3	
Carfentanyl		0.005		0.00125	0.0075	
Cocaine	0.75	1	0.1	0.2	2	
Codeine (except when included in schedule 2, 3 or 4)		2		0.5	125	
Codeine‑N‑oxide		10		2.5	15	
4‑Cyano‑1‑methyl‑4-phenylpiperidine (pethidine intermediate A)		1		0.25	3	
Cyclobarbitone		4		1	125	
Dexamphetamine						
Dextromoramide		1.5		0.6	30	
Dextropropoxyphene (except when included in schedule 4)						
Difenoxin (except when included in schedule 4)		2		0.5	100	
Dihydrocodeine (except when included in schedule 2, 3 or 4)		10		2.5	250	
Dihydromorphine		10		2.5	250	
Diphenoxylate (except when included in schedule 3 or 4)		2		0.5	125	
Dipipanone		10		2.5	125	
Dronabinol (delta‑9-tetrahydrocannabinol) when prepared and packed for therapeutic use						
Drotebanol		1		0.25	3	
Ethylamphetamine						
Ethylmorphine (except when included in schedule 2 or 4)		2		0.5	3	
Fentanyl		0.005		0.00125	0.0075	
Flunitrazepam		1.5		0.6	30	
Hydrocodone		2		0.5	3	
Hydromorphinol		2		0.5	3	
Hydromorphone		2		0.5	3	
Ketamine		2		0.5	6	
Levamphetamine						
Levomethamphetamine						
Levomoramide						
Levorphanol (excluding its stereoisomers)		1		0.25	1.5	
Methadone		20		4	400	
1‑Methyl‑4‑phenylpiperidine‑4‑
carboxylic acid (pethidine intermediate C)		1		0.25	3	
Methylamphetamine (Methamphetamine)	0.75	1	0.1	0.5	2	
Methyldihydromorphine		2		0.5	3	
Methylphenidate		2		0.5	3	
Morphine		1		0.2	20	
Morphine methobromide		1.5		0.6	30	
Morphine‑N‑oxide		1.5		0.6	30	
Nabilone		0.4		0.1	0.6	
Norcodeine		4		1	500	
Normethadone		5		1.25	7.5	
Opium (except the alkaloids noscapine when included in schedule 2 and papaverine when included in schedule 2 or 4)		4		1	30	
Oxycodone		5		1.25	7.5	
Oxymorphone		2		0.5	3	
Pentazocine		5		1.25	125	
Pentobarbitone (except when included in schedule 4)		4		1	125	
Pethidine		1		0.2	20	
Phendimetrazine		10		2.5	15	
Phenmetrazine		5		1.25	7.5	
Phenoperidine		5		1.25	7.5	
4‑Phenylpiperidine‑4‑carboxylic acid ethyl ester (pethidine intermediate B)		1		0.25	3	
Pholcodine (except when included in schedule 2 or 4)		5		1.25	7.5	
Piritramide		1		0.25	1.5	
Concentrate of poppy straw						
Propiram		2		0.5	3	
Quinalbarbitone		4		1	125	
Racemoramide						
Remifentanil		0.2		0.05	0.3	
Secbutobarbitone		4		1	125	
Sufentanil		0.005		0.00125	0.0075	
Thebacon		2		0.5	3	
Thebaine		2		0.5	3	
Tilidine		1		0.25	3	

Schedule 2—Controlled precursors

	Large commercial (mixed)	Commercial (mixed)	
	kg / L	kg / L	
Acetaldehyde	2 kg	0.5 kg	
Acetic anhydride	4 L	1 L	
N‑Acetylanthranilic acid	20 kg	5 kg	
Allylbenzene	1 L	0.25 L	
Allylpyrocatechol	0.4 L	0.1 L	
Alpha‑phenylacetoacetonitrile	2 kg	0.5 kg	
4‑Aminobutanoic acid	6 kg	1.5 kg	
Ammonia	6 kg	1.5 kg	
Ammonium formate	2 kg	0.5 kg	
Anethole	0.4L	0.1L	
Anthranilic acid	20 kg	5 kg	
Benzaldehyde	2 L	0.5 L	
1,3‑Benzodioxole	1 L	0.25 L	
Benzyl bromide	2 L	0.5 L	
Benzyl chloride	2 L	0.5 L	
Boron tribromide	1 L	0.25 L	
Bromobenzene	2 L	0.5 L	
5-Bromo‑1,3‑benzodioxole	1 L	0.25 L	
Bromosafrole	0.2 L	0.05 L	
1,4‑Butanediol	6 L	1.5 L	
Calcium	1 kg	0.25 kg	
1‑Chlorophenyl‑2‑aminopropane	1 kg	0.25 kg	
Chromic acid	0.4 L	0.1 L	
Chromium trioxide	0.4 kg	0.1 kg	
Ephedrine	1 kg	0.25 kg	
Ergometrine	0.0002 kg	0.00005 kg	
Ergotamine	0.02 kg	0.005 kg	
Ethanamine	2 L	0.5 L	
Ethyl phenyl acetate	2 kg	0.5 kg	
N‑Ethylephedrine	1 kg	0.25 kg	
N‑Ethylpseudoephedrine	1 kg	0.25 kg	
Eugenol	0.4 L	0.1 L	
Formaldehyde	6 kg	1.5 kg	
Formamide	2 L	0.5 L	
Hydriodic acid	4 L	1 L	
Hydrobromic acid	1 L	0.25 L	
Hydrogen	6 kg	1.5 kg	
Hydrogen chloride	6 kg	1.5 kg	
Hydrogen sulfide	6 kg	1.5 kg	
4‑Hydroxybutanal	6 L	1.5 L	
4‑Hydroxybutanoic acid lactone	6 L	1.5 L	
4‑Hydroxybutanoic acid nitrile	6 L	1.5 L	
4‑Hydroxypentanoic acid	6 L	1.5 L	
2‑Hydroxytetrahydrofuran	6 L	1.5 L	
Hypophosphite salts	1 kg	0.25 kg	
Hypophosphorous acid	1 L	0.25 L	
Iodine	1 kg	0.25 kg	
Isosafrole	0.4 L	0.1 L	
Lithium	1 kg	0.25 kg	
Lithium aluminium hydride	0.2 kg	0.05 kg	
Lysergic acid	0.0002 kg	0.00005 kg	
Magnesium	1 kg	0.25 kg	
Mandellic acid	2 kg	0.5 kg	
Mercuric chloride	0.004 kg	0.001 kg	
Mercury	0.004 kg	0.001 kg	
Methcathinone	1 kg	0.25kg	
Methylamine	2 L	0.5 L	
Methylammonium salts	1 kg	0.25 kg	
3,4‑Methylenedioxyphenylacetic acid	0.4 kg	0.1 kg	
3,4‑Methylenedioxyphenylpropan‑2‑one (PMK)	1L	0.25L	
N‑Methylformamide	2 L	0.5 L	
N‑Methylephedrine	1 kg	0.25 kg	
Methyl phenylacetate	2 kg	0.5 kg	
N‑Methylpseudoephedrine	1 kg	0.25 kg	
Trans β‑Methylstyrene	2 L	0.5 L	
Nitroethane	2 L	0.5 L	
Nitromethane	2 L	0.5 L	
Norpseudoephedrine	1 kg	0.25 kg	
Palladium	0.02 kg	0.005 kg	
Phenylacetamide	2 kg	0.5 kg	
Phenylacetic acid	2 kg	0.5 kg	
Phenylacetonitrile	2 L	0.5 L	
Phenylacetyl chloride	2 L	0.5 L	
Phenylalanine	2 kg	0.5 kg	
1‑Phenyl‑2‑bromopropane	2 kg	0.5 kg	
1‑Phenyl‑2‑chloropropane	2 kg	0.5 kg	
1‑Phenyl‑2‑iodopropane	2 kg	0.5 kg	
1‑Phenyl‑2‑nitropropene	1 kg	0.25 kg	
Phenylpropanolamine	2 kg	0.5 kg	
1‑Phenyl‑2‑propanol	1 L	0.25 L	
1‑Phenyl‑1‑Propanone	1 L	0.25 L	
1‑Phenyl‑2‑propanone (BMK)	1 L	0.25 L	
1‑Phenyl‑2‑propanone oxime	1 kg	0.25 kg	
Phosphorus	0.4 kg	0.1 kg	
Phosphorous acid	1 L	0.25 L	
Piperidine	0.2 kg	0.05 kg	
Piperonal	0.4 kg	0.1kg	
Platinum	0.02 kg	0.005 kg	
Potassium	1 kg	0.25 kg	
Propionic anhydride	0.2 L	0.05 L	
Pseudoephedrine	1 kg	0.25 kg	
Pyridine	4 L	1 L	
2-Pyrrolidone	6 L	1.5 L	
Raney nickel	0.2 kg	0.05 kg	
Safrole	0.4 L	0.1 L	
Sassafras oil	0.4 L	0.1 L	
Sodium	1 kg	0.25 kg	
Sodium bis(2‑methoxyethoxy) aluminium hydride	0.2 kg	0.05 kg	
Sodium borohydride	0.2 kg	0.05 kg	
Sodium cyanoborohydride	0.2 kg	0.05 kg	
Thionyl chloride	1 kg	0.25 kg	
Thorium	4 kg	1 kg	

Schedule 3—Controlled plants
Part 1—Controlled plants other than cannabis plants

	Large commercial	Commercial	Trafficable	
any plant of the genus Erythroxylum P. Browne) from which cocaine can be extracted either directly or by chemical transformation, including Erythroxylum coca Lam and Erythroxylum nova‑granatense	800kg	80kg	800g	
Papaver bracteatum Lindley		(a)	if each plant weighs less than 100g—10 000 plants; or		(a)	if each plant weighs less than 100g—1000 plants; or		(a)	if each plant weighs less than 10g—100 plants; or	
		(b)	in any other case—1000kg		(b)	in any other case—100kg		(b)	in any other case—1kg	
Papaver somniferum L		(a)	if each plant weighs less than 100g—10 000 plants; or		(a)	if each plant weighs less than 100g—1000 plants; or		(a)	if each plant weighs less than 10g—100 plants; or	
		(b)	in any other case—1000kg		(b)	in any other case—100kg		(b)	in any other case—1kg	
all fungi that contain PSILOCIN	10kg	2.5kg	1000g	
all fungi that contain PSILOCYBIN	10kg	2.5kg	1000g	
any plant containing MESCALINE including any plant of the genus Lophophora				
Salvia divinorum EPL. & Jativa (Diviners Sage)				
Mitragyna speciosa Korth (Kratom)				
Catha edulis Forsk (Khat)	5kg	2.5kg	250g	
any species of the genus Ephedra which contains ephedrine	200kg	50kg	10kg	
any species of the genus Brugmansia Pers				
any species of the genus Datura L				

Part 2—Cannabis plants

	Large commercial	Commercial	Trafficable	
any plant of the genus Cannabis L	100 plants	20 plants	10 plants	

Schedule 4—Certificate of analysis
(regulation 12)

Schedule 5—Expiation fees

1	Offence arising out of the possession of cannabis—		
		•	where the amount is less than 25g	$150	
		•	where the amount is 25g or more but less than 100g	$300	
2	Offence arising out of the possession of cannabis resin—		
		•	where the amount is less than 5g	$150	
		•	where the amount is 5g or more but less than 20g	$300	
3	Offence arising out of the smoking or consumption of cannabis or cannabis resin (not being an offence committed in a public place or other prescribed place)	$150	
4	Offence arising out of the possession of equipment (1 or more pieces) for use in connection with the smoking or consumption of cannabis or cannabis resin (not being an offence involving the possession of such equipment for commercial purposes)	$150	
5	Offence referred to in item 4 accompanied by another simple cannabis offence relating to the possession, smoking or consumption of cannabis or cannabis resin	$30	
6	Offence involving cultivation of 1 cannabis plant	$300	

Legislative history
Notes
	•	Variations of this version that are uncommenced are not incorporated into the text.
	•	Please note—References in the legislation to other legislation or instruments or to titles of bodies or offices are not automatically updated as part of the program for the revision and publication of legislation and therefore may be obsolete.
	•	Earlier versions of these regulations (historical versions) are listed at the end of the legislative history.
	•	For further information relating to the Act and subordinate legislation made under the Act see the Index of South Australian Statutes or www.legislation.sa.gov.au.
Formerly
Controlled Substances (Prohibited Substances) Regulations 2000
Legislation revoked by principal regulations
The Controlled Substances (General) Regulations 2000 revoked the following:
Controlled Substances (Declared Prohibited Substances) Regulations 1985
Principal regulations and variations
New entries appear in bold.
Year	No	Reference	Commencement	
2000	199	Gazette 31.8.2000 p1002	31.8.2000: r 2	
2003	36	Gazette 10.4.2003 p1675	10.4.2003: r 2	
2007	264	Gazette 22.11.2007 p4308	3.12.2007: r 2	
2008	276	Gazette 16.10.2008 p4870	19.10.2008: r 2	
2008	278	Gazette 23.10.2008 p4936	23.10.2008: r 2	
2009	213	Gazette 30.7.2009 p3450	4.8.2009: r 2	
2009	236	Gazette 10.9.2009 p4426	10.9.2009: r 2	
2010	40	Gazette 3.6.2010 p2162	3.6.2010: r 2	
2011	141	Gazette 9.6.2011 p2377	1.7.2011: r 2	
Provisions varied
New entries appear in bold.
Entries that relate to provisions that have been deleted appear in italics.
Provision	How varied	Commencement	
r 1	varied by 264/2007 r 4	3.12.2007	
rr 2 and 3	deleted by 264/2007 r 5	3.12.2007	
r 4			
DDU	inserted by 236/2009 r 4	10.9.2009	
midwife	inserted by 213/2009 r 4	4.8.2009	
	substituted by 40/2010 r 4	3.6.2010	
schedule 8	deleted by 264/2007 r 6	3.12.2007	
r 4A	inserted by 278/2008 r 4	23.10.2008	
r 5	substituted by 264/2007 r 7	3.12.2007	
r 6	substituted by 264/2007 r 7	3.12.2007	
r 6(1)	varied by 236/2009 r 5(1), (2)	10.9.2009	
	(b) deleted by 236/2009 r 5(3)	10.9.2009	
r 6(2)	varied by 236/2009 r 5(4)	10.9.2009	
r 6(2a)	inserted by 236/2009 r 5(5)	10.9.2009	
r 6(3)	varied by 236/2009 r 5(6), (7)	10.9.2009	
	(b) deleted by 236/2009 r 5(8)	10.9.2009	
r 6(4)	varied by 236/2009 r 5(9)	10.9.2009	
r 6(4a)	inserted by 236/2009 r 5(10)	10.9.2009	
r 6(7)	inserted by 236/2009 r 5(11)	10.9.2009	
r 6A	inserted by 213/2009 r 5	4.8.2009	
r 6A(1)	varied by 40/2010 r 5	3.6.2010	
rr 7 and 8	substituted by 264/2007 r 7	3.12.2007	
r 8AA	inserted by 276/2008 r 4	19.10.2008	
rr 8AB and 8AC	inserted by 236/2009 r 6	10.9.2009	
r 8A	inserted by 264/2007 r 7	3.12.2007	
r 9	varied by 264/2007 r 8	3.12.2007	
	varied by 40/2010 r 6	3.6.2010	
rr 9A and 9B	inserted by 264/2007 r 9	3.12.2007	
r 10			
r 10(1)	varied by 278/2008 r 5	23.10.2008	
r 11	varied by 264/2007 r 10	3.12.2007	
r 14	inserted by 264/2007 r 11	3.12.2007	
	(a)(iv) deleted by 236/2009 r 7(1)	10.9.2009	
	varied by 236/2009 r 7(2)	10.9.2009	
rr 14—16	inserted by 264/2007 r 11	3.12.2007	
Sch 1	varied by 36/2003 r 4	10.4.2003	
	substituted by 264/2007 r 12	3.12.2007	
	varied by 236/2009 r 8(1)—(49)	10.9.2009	
	varied by 40/2010 r 7(1)—(3)	3.6.2010	
Sch 2	substituted by 264/2007 r 12	3.12.2007	
	varied by 236/2009 r 9(1)—(4)	10.9.2009	
Sch 3	substituted by 264/2007 r 12	3.12.2007	
	varied by 236/2009 r 10	10.9.2009	
Sch 5	inserted by 264/2007 r 13	3.12.2007	
Historical versions
Reprint 1—10.4.2003		
3.12.2007		
19.10.2008		
23.10.2008		
4.8.2009		
10.9.2009